Abstract
As discussed in Chapter 10, for determination of dierent dosimetric parameters implemented in the internationally established TG-43 (Nath et al. 1995) and TG-43U1 (Rivard et al. 2004) dosimetry protocol, experimentally validated MC simulation results are required. is recommendation has been extended in the AAPM and ESTRO report on dose calculation for photonemitting brachytherapy sources with average energy higher than 50 keV (Li et al. 2007; Pérez-Calatayud et al. 2012). Furthermore, the need for investigating and quantifying the dose perturbation arising from simple or complex applicator geometries and applicator materials (plastic or metal), shielding materials, and tissue inhomogeneities necessitates the availability of appropriate experimental dosimetry systems in modern brachytherapy.
| Original language | English |
|---|---|
| Title of host publication | Comprehensive Brachytherapy |
| Subtitle of host publication | Physical and Clinical Aspects |
| Pages | 75-83 |
| Number of pages | 9 |
| ISBN (Electronic) | 9781439844991 |
| DOIs | |
| State | Published - Jan 1 2012 |
Bibliographical note
Publisher Copyright:© 2013 by Taylor and Francis Group, LLC.
ASJC Scopus subject areas
- General Physics and Astronomy
- General Engineering
- General Biochemistry, Genetics and Molecular Biology
- General Medicine